Adverse effect of antiparkns drug/centr musc-tone depr, init

This code signifies an undesirable or harmful reaction experienced by a patient due to the therapeutic use of antiparkinsonism medications or other central muscle-tone depressants. This adverse effect occurred during the initial period of treatment or during the first encounter for this specific complication.

Apply this code when a patient presents with a new adverse reaction to a prescribed antiparkinsonism drug (e.g., levodopa, carbidopa) or a centrally acting muscle relaxant (e.g., baclofen, tizanidine). This includes scenarios like acute dystonia, dyskinesia, or severe sedation directly attributable to the medication.

• Always sequence this code first, followed by codes for the specific manifestation of the adverse effect.
• Ensure documentation clearly links the adverse effect to the specific drug class and indicates it's the initial presentation.
• Distinguish adverse effects from poisoning or underdosing, as these have different code categories.